Serum immunosuppressive acidic protein and natural killer cell activity in patients with metastatic renal cell carcinoma before and after nephrectomy

被引:25
作者
Fujikawa, K [1 ]
Matsui, Y [1 ]
Miura, K [1 ]
Kobayashi, T [1 ]
Oka, H [1 ]
Fukuzawa, S [1 ]
Takeuchi, H [1 ]
机构
[1] Kobe City Gen Hosp, Dept Urol, Chuo Ku, Kobe, Hyogo 650, Japan
关键词
kidney; carcinoma; renal cell; neoplasm metastasis; nephrectomy; C-reactive protein;
D O I
10.1016/S0022-5347(05)67278-3
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: To our knowledge the impact of nephrectomy on stage M1 renal cell carcinoma remains to be determined. We previously reported that nephrectomy is beneficial in patients with elevated serum C-reactive protein before treatment, and those in whom nadir C-reactive protein decreases postoperatively to within the normal range may expect longer survival when surgery is combined with postoperative immunotherapy. In this study we determine the effect of nephrectomy on the immune response in patients with metastatic renal cell carcinoma. Materials and Methods: We retrospectively reviewed the records of 40 patients with metastatic renal cell carcinoma diagnosed at our institution between 1986 and 1999. These patients underwent nephrectomy before cytokine therapy with interferon. Before and after nephrectomy we measured serum C-reactive protein, serum immunosuppressive acidic protein and peripheral blood natural killer cell activity. Results: In 15 patients with pretreatment serum C-reactive protein within the normal range (less than 1 ng./ml.) there was no significant difference before and after nephrectomy in the serum immunosuppressive acidic protein level or natural killer cell activity (p = 0.4587 and 0.3892, respectively). On the other hand, in 25 patients with serum C-reactive protein elevated before treatment to 1 ng./ml. or greater serum immunosuppressive acidic protein decreased significantly and natural killer cell activity increased significantly after cytoreductive surgery (p = 0.0002 and 0.0286, respectively). Conclusions: Our study implies that nephrectomy may be beneficial in patients with elevated serum C-reactive protein before treatment. Further evaluation by a prospective study is needed to make a definitive conclusion.
引用
收藏
页码:673 / 675
页数:3
相关论文
共 17 条
  • [1] CYTOREDUCTIVE SURGERY FOR STAGE-IV RENAL-CELL CARCINOMA
    BENNETT, RT
    LERNER, SE
    TAUB, HC
    DUTCHER, JP
    FLEISCHMANN, J
    [J]. JOURNAL OF UROLOGY, 1995, 154 (01) : 32 - 34
  • [2] BLOOM HJG, 1973, CANCER, V32, P1066, DOI 10.1002/1097-0142(197311)32:5<1066::AID-CNCR2820320507>3.0.CO
  • [3] 2-F
  • [4] IMMUNOLOGICAL PARAMETERS IN PERIPHERAL-BLOOD OF PATIENTS WITH RENAL-CELL CARCINOMA BEFORE AND AFTER NEPHRECTOMY
    DADIAN, G
    RICHES, PG
    HENDERSON, DC
    TAYLOR, A
    MOORE, J
    ATKINSON, H
    GORE, ME
    [J]. BRITISH JOURNAL OF UROLOGY, 1994, 74 (01): : 15 - 22
  • [5] METASTATIC RENAL-CANCER TREATED WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS - A PHASE-II CLINICAL-TRIAL
    FISHER, RI
    COLTMAN, CA
    DOROSHOW, JH
    RAYNER, AA
    HAWKINS, MJ
    MIER, JW
    WIERNIK, P
    MCMANNIS, JD
    WEISS, GR
    MARGOLIN, KA
    GEMLO, BT
    HOTH, DF
    PARKINSON, DR
    PAIETTA, E
    [J]. ANNALS OF INTERNAL MEDICINE, 1988, 108 (04) : 518 - 523
  • [6] Serum C-reactive protein level and the impact of cytoreductive surgery in patients with metastatic renal cell carcinoma
    Fujikawa, K
    Matsui, Y
    Oka, H
    Fukuzawa, S
    Takeuchi, H
    [J]. JOURNAL OF UROLOGY, 1999, 162 (06) : 1934 - 1937
  • [7] RESULTS OF TREATMENT OF 255 PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA WHO RECEIVED HIGH-DOSE RECOMBINANT INTERLEUKIN-2 THERAPY
    FYFE, G
    FISHER, RI
    ROSENBERG, SA
    SZNOL, M
    PARKINSON, DR
    LOUIE, AC
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (03) : 688 - 696
  • [8] HERMANEK P, 1987, TNM CLASSIFICATION M, P136
  • [9] LITZOVA E, 1986, COMP IMMUNOL MICROB, V9, P185
  • [10] PROGNOSTIC FACTORS FOR SURVIVAL IN PATIENTS WITH METASTATIC RENAL-CANCER TREATED WITH BIOLOGICAL RESPONSE MODIFIERS
    MANI, S
    TODD, MB
    KATZ, K
    POO, WJ
    [J]. JOURNAL OF UROLOGY, 1995, 154 (01) : 35 - 40